BACKGROUND: Dietary fat in dairy is a source of estrogenic hormones and may be related to worse breast cancer survival. We evaluated associations between high- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. METHODS: We included 1893 women from the Life After Cancer Epidemiology study diagnosed with early-stage invasive breast cancer from 1997 to 2000, who completed the Fred Hutchinson Cancer Research Center Food Frequency Questionnaire after diagnosis. A total of 349 women had a recurrence and 372 died during a median follow-up of 11.8 years, with 189 deaths from breast cancer. We used delayed entry Cox proportional hazards regression to evaluate associations between categories of the cumulative average of dairy fat at baseline and at follow-up 5 to 6 years later and subsequent outcomes. Tests of statistical significance were two-sided. RESULTS: In multivariable-adjusted analyses, overall dairy intake was unrelated to breast cancer-specific outcomes, although it was positively related to overall mortality. Low-fat dairy intake was unrelated to recurrence or survival. However, high-fat dairy intake was positively associated with outcomes. Compared with the reference (0 to <0.5 servings/day), those consuming larger amounts of high-fat dairy had higher breast cancer mortality (0.5 to <1.0 servings/day: hazard ratio [HR] = 1.20, 95% confidence interval [CI] = 0.82 to 1.77; and ≥1.0 servings/day: HR = 1.49, 95% CI = 1.00 to 2.24, P trend = .05), higher all-cause mortality (P trend < .001), and higher non-breast cancer mortality (P trend = .007); the relationship with breast cancer recurrence was positive but not statistically significant. The higher risk appeared consistent across different types of high-fat dairy products. CONCLUSIONS: Intake of high-fat dairy, but not low-fat dairy, was related to a higher risk of mortality after breast cancer diagnosis.
BACKGROUND: Dietary fat in dairy is a source of estrogenic hormones and may be related to worse breast cancer survival. We evaluated associations between high- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. METHODS: We included 1893 women from the Life After Cancer Epidemiology study diagnosed with early-stage invasive breast cancer from 1997 to 2000, who completed the Fred Hutchinson Cancer Research Center Food Frequency Questionnaire after diagnosis. A total of 349 women had a recurrence and 372 died during a median follow-up of 11.8 years, with 189 deaths from breast cancer. We used delayed entry Cox proportional hazards regression to evaluate associations between categories of the cumulative average of dairy fat at baseline and at follow-up 5 to 6 years later and subsequent outcomes. Tests of statistical significance were two-sided. RESULTS: In multivariable-adjusted analyses, overall dairy intake was unrelated to breast cancer-specific outcomes, although it was positively related to overall mortality. Low-fat dairy intake was unrelated to recurrence or survival. However, high-fat dairy intake was positively associated with outcomes. Compared with the reference (0 to <0.5 servings/day), those consuming larger amounts of high-fat dairy had higher breast cancer mortality (0.5 to <1.0 servings/day: hazard ratio [HR] = 1.20, 95% confidence interval [CI] = 0.82 to 1.77; and ≥1.0 servings/day: HR = 1.49, 95% CI = 1.00 to 2.24, P trend = .05), higher all-cause mortality (P trend < .001), and higher non-breast cancer mortality (P trend = .007); the relationship with breast cancer recurrence was positive but not statistically significant. The higher risk appeared consistent across different types of high-fat dairy products. CONCLUSIONS: Intake of high-fat dairy, but not low-fat dairy, was related to a higher risk of mortality after breast cancer diagnosis.
Authors: P van't Veer; J M Dekker; J W Lamers; F J Kok; E G Schouten; H A Brants; F Sturmans; R J Hermus Journal: Cancer Res Date: 1989-07-15 Impact factor: 12.701
Authors: Stacey A Missmer; Stephanie A Smith-Warner; Donna Spiegelman; Shiaw-Shyuan Yaun; Hans-Olov Adami; W Lawrence Beeson; Piet A van den Brandt; Gary E Fraser; Jo L Freudenheim; R Alexandra Goldbohm; Saxon Graham; Lawrence H Kushi; Anthony B Miller; John D Potter; Thomas E Rohan; Frank E Speizer; Paolo Toniolo; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; David J Hunter Journal: Int J Epidemiol Date: 2002-02 Impact factor: 7.196
Authors: Myung-Hee Shin; Michelle D Holmes; Susan E Hankinson; Kana Wu; Graham A Colditz; Walter C Willett Journal: J Natl Cancer Inst Date: 2002-09-04 Impact factor: 13.506
Authors: Cristina Palacios; Carrie R Daniel; Maribel Tirado-Gómez; Velda Gonzalez-Mercado; Liliana Vallejo; Jose Lozada; Alexis Ortiz; Daniel C Hughes; Karen Basen-Engquist Journal: J Immigr Minor Health Date: 2017-04
Authors: Maryam S Farvid; Michelle D Holmes; Wendy Y Chen; Bernard A Rosner; Rulla M Tamimi; Walter C Willett; A Heather Eliassen Journal: Cancer Res Date: 2020-11-15 Impact factor: 12.701
Authors: Gianluca Tognon; Lena M Nilsson; Dmitry Shungin; Lauren Lissner; Jan-Håkan Jansson; Frida Renström; Maria Wennberg; Anna Winkvist; Ingegerd Johansson Journal: Am J Clin Nutr Date: 2017-05-10 Impact factor: 7.045
Authors: Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Michael S Simon; JoAnn E Manson; Marian L Neuhouser; Kathy Pan; Marcia L Stefanic; Thomas E Rohan; Dorothy Lane; Lihong Qi; Linda Snetselaar; Ross L Prentice Journal: JAMA Oncol Date: 2018-10-11 Impact factor: 31.777
Authors: Rowan T Chlebowski; Aaron K Aragaki; Garnet L Anderson; Cynthia A Thomson; JoAnn E Manson; Michael S Simon; Barbara V Howard; Thomas E Rohan; Linda Snetselar; Dorothy Lane; Wendy Barrington; Mara Z Vitolins; Catherine Womack; Lihong Qi; Lifang Hou; Fridtjof Thomas; Ross L Prentice Journal: J Clin Oncol Date: 2017-06-27 Impact factor: 44.544
Authors: Kisha I Coa; Katherine Clegg Smith; Ann C Klassen; Laura E Caulfield; Kathy Helzlsouer; Kim Peairs; Lillie Shockney Journal: Support Care Cancer Date: 2014-08-28 Impact factor: 3.603
Authors: Caroline E Boeke; A Heather Eliassen; Wendy Y Chen; Eunyoung Cho; Michelle D Holmes; Bernard Rosner; Walter C Willett; Rulla M Tamimi Journal: Breast Cancer Res Treat Date: 2014-06-04 Impact factor: 4.872